Thermo Fisher Scientific (TMO) SVP & General Counsel reports Form 4 stock sale

Rhea-AI Filing Summary

Thermo Fisher Scientific executive Thomas B. Shropshire, Jr., who serves as SVP and General Counsel, reported a change in his holdings of the company’s common stock. On 12/02/2025, he disposed of 337.476 shares of Thermo Fisher common stock in a transaction coded “F” at a price of $580.37 per share. After this transaction, he beneficially owned 5,079.524 shares, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shropshire Thomas B Jr.

(Last) (First) (Middle)

168 THIRD AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/02/2025		F		337.476	D	$580.37	5,079.524	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Melodie T. Morin, Attorney-in-Fact for Thomas B. Shropshire, Jr.	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Thermo Fisher Scientific (TMO) report for Thomas B. Shropshire, Jr.?

The filing reports that on 12/02/2025, Thomas B. Shropshire, Jr. disposed of 337.476 shares of Thermo Fisher Scientific common stock at $580.37 per share in a transaction coded “F”.

What is Thomas B. Shropshire, Jr.’s role at Thermo Fisher Scientific (TMO)?

Thomas B. Shropshire, Jr. is reported as an officer of Thermo Fisher Scientific, holding the title of SVP and General Counsel.

How many Thermo Fisher Scientific (TMO) shares does Thomas B. Shropshire, Jr. own after the reported transaction?

Following the 12/02/2025 transaction, Thomas B. Shropshire, Jr. beneficially owned 5,079.524 shares of Thermo Fisher Scientific common stock, held directly.

What type of SEC form reported this Thermo Fisher Scientific (TMO) insider transaction?

The transaction was reported on an SEC Form 4, which discloses changes in beneficial ownership by company insiders.

Was the Thermo Fisher Scientific (TMO) Form 4 filed by one or multiple reporting persons?

The Form 4 indicates it was filed by one reporting person, Thomas B. Shropshire, Jr.

Does the Thermo Fisher Scientific (TMO) Form 4 mention derivative securities for this transaction?

The filing includes a section for derivative securities, but no specific derivative transactions are listed in the provided table excerpt.